Stock Events

Stock Events

Adaptive Biotechnologies 

$13.17
120
+$0.72+5.78% Friday 20:00

Statistics

Day High
13.28
Day Low
12.69
52W High
20.76
52W Low
6.68
Volume
3,892,105
Avg. Volume
2,024,155
Mkt Cap
2.03B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.29
-0.17
-0.06
0.06
Expected EPS
-0.1586
Actual EPS
N/A

Financials

-21.48%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
553.95MRevenue
-119MNet Income

Analyst Ratings

$20.00Average Price Target
The highest estimate is 22.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
80%
Hold
20%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ADPT. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap18.99B
Illumina provides genomic sequencing solutions and competes with Adaptive Biotechnologies in the genomic analysis market.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Pacific Biosciences offers long-read sequencing technologies that compete with Adaptive's platforms for comprehensive genomic profiling.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics is involved in gene editing, a field that overlaps with Adaptive's focus on leveraging genetic information for medical solutions.
Intellia Therapeutics
NTLA
Mkt Cap1.35B
Intellia Therapeutics is another key player in the gene editing space, competing with Adaptive in the development of genetically informed therapies.
Editas Medicine
EDIT
Mkt Cap276.95M
Editas Medicine operates in the gene editing industry, directly competing with Adaptive Biotechnologies in the pursuit of personalized medicine solutions.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health specializes in liquid biopsies and cancer diagnostics, competing with Adaptive in the oncology diagnostics market.
Exact Sciences
EXAS
Mkt Cap12.25B
Exact Sciences provides cancer screening and diagnostic tests, competing with Adaptive Biotechnologies in the field of cancer detection.
Bionano Genomics
BNGO
Mkt Cap17.42M
Bionano Genomics offers genomic analysis tools, competing with Adaptive in the market for genetic research and clinical applications.

About

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. It has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
Show more...
CEO
Mr. Chad M. Robins M.B.A.
Employees
619
Country
US
ISIN
US00650F1093

Listings

XNAS
US
ADPT
F
DE
1HM.F
BOATS
BOATS
ADPT.BOATS

0 Comments

Share your thoughts

FAQ

What is Adaptive Biotechnologies stock price today?▼
The current price of ADPT is $13.17 USD — it has increased by +5.78% in the past 24 hours. Watch Adaptive Biotechnologies stock price performance more closely on the chart.
What is Adaptive Biotechnologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Adaptive Biotechnologies stocks are traded under the ticker ADPT.
Is Adaptive Biotechnologies stock price growing?▼
ADPT stock has fallen by -11.37% compared to the previous week, the month change is a -17.89% fall, over the last year Adaptive Biotechnologies has showed a +80.91% increase.
What is Adaptive Biotechnologies market cap?▼
Today Adaptive Biotechnologies has the market capitalization of 2.03B
When is the next Adaptive Biotechnologies earnings date?▼
Adaptive Biotechnologies is going to release the next earnings report on May 06, 2026.
What were Adaptive Biotechnologies earnings last quarter?▼
ADPT earnings for the last quarter are -0.09 USD per share, whereas the estimation was -0.19 USD resulting in a +51.49% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Adaptive Biotechnologies revenue for the last year?▼
Adaptive Biotechnologies revenue for the last year amounts to 553.95M USD.
What is Adaptive Biotechnologies net income for the last year?▼
ADPT net income for the last year is -119M USD.
How many employees does Adaptive Biotechnologies have?▼
As of March 15, 2026, the company has 619 employees.
In which sector is Adaptive Biotechnologies located?▼
Adaptive Biotechnologies operates in the Health Care sector.
When did Adaptive Biotechnologies complete a stock split?▼
Adaptive Biotechnologies has not had any recent stock splits.
Where is Adaptive Biotechnologies headquartered?▼
Adaptive Biotechnologies is headquartered in Seattle, US.